Skip to main content

最新 NAFLD/NASH 臨床前模型數據將在 ADA 2020 公佈

Written by Customer Service on . Posted in Public Companies.

聖地牙哥, June 10, 2020 (GLOBE NEWSWIRE) — Crown Bioscience 今天宣佈發佈最新專屬的 NAFLD/NASH 臨床前模型開發數據。數據將在美國糖尿病協會 (ADA) 第 80 屆科學年會及 CrownBio 的輔助虛擬活動公佈。
新數據將分享在 CrownBio 的高轉化性囓齒類動物和 NHP 臨床前模型庫中改善飲食而達成的 NAFLD/NASH 模型開發。這些模型將促進臨床前 NAFLD/NASH 藥物開發，而這個疾病領域目前仍未有任何治療獲得批准。除 ADA 2020 海報外，CrownBio 也會透過 6 月 12 日的 NAFLD/NASH 模型開發演示以支持同日的「國際非酒精性脂肪肝炎日」。CrownBio 將舉辦一個免費的虛擬活動，公開提供所有這些資源，詳情載於 CrownBio.com/ADA20。CrownBio 血管與代謝疾病高級副總裁 Jim Wang 醫生表示：「我們致力透過繼續增強公司高度轉化臨床前模型平台來進一步促進和發展 NAFLD/NASH。我們很高興有機會在今年 6 月一系列創新的虛擬活動中就這個仍未能滿足需求的領域方面分享我們的最新研究。」CrownBio 的虛擬 ADA 活動舉行日期為 6 月 12 至 16 日，網址為 CrownBio.com/ADA20。年會將鼓勵各方與 CrownBio 心血管和代謝疾病團隊投入討論，參與者也可查閱和下載包括 NAFLD/NASH 在內各疾病領域的各種資源，包括糖尿病、肥胖症、腎病和心血管疾病。關於 Crown Bioscience Inc.Crown Bioscience 是一家 JSR 生命科學公司，是一家全球藥物研發和開發服務公司，提供轉化平台以推進腫瘤學、炎症和代謝疾病研究。憑著廣泛的相關模型和預測工具組合，Crown Bioscience 使客戶能夠提供優質的臨床候選產品。如欲了解更多詳情，請瀏覽：https://www.crownbio.comhttps://www.jsrlifesciences.com傳媒查詢：Crown Bioscience 
 Jody Barbeau
pr@crownbio.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.